Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Eli Lilly · Phase 1 · Recruiting · Enrollment 56

NCT07738614

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Eloralintide Cohort 1n/rn/rn/rn/r
Eloralintide Cohort 2n/rn/rn/rn/r
Eloralintide Cohort 3n/rn/rn/rn/r
Eloralintide Cohort 4n/rn/rn/rn/r
Placebon/rn/rn/rn/r

Not shown

  • Eloralintide Cohort 1: endpoint not reported
  • Eloralintide Cohort 2: endpoint not reported
  • Eloralintide Cohort 3: endpoint not reported
  • Eloralintide Cohort 4: endpoint not reported
  • Placebo: endpoint not reported